Navigation Links
First, do no harm: Study finds danger in standard treatment for a serious lung disease
Date:5/20/2012

to those in the trial, say the authors.

And, the dramatic finding of harm from a standard treatment should cause physicians to apply rigorous testing methods to other types of treatment, and highlights the importance of independent federal funding for such studies, says Martinez.

The authors salute the volunteer IPF patients who agreed to be randomly assigned to a treatment or placebo for 60 weeks.

Martinez, an internationally known IPF researcher and clinician in the U-M Medical School's Division of Pulmonary Medicine, remarks that results will soon be known for the group taking NAC alone, compared with those taking placebo. The current paper and presentation do not include results from this group.

In the results presented this week, the authors report that eight patients in the group of 77 assigned to the three-drug combination died, compared with one in the placebo group. A total of 23 of the three-drug patients were hospitalized during the trial, compared with 7 in the placebo group. There was no sign that the three-drug combination slowed the progression of IPF or improved lung function, as measured by forced vital capacity.

The study is called PANTHER-IPF, for Prednisone, Azathioprine, and N-Acetylcysteine: a Study That Evaluates Response in Idiopathic Pulmonary Fibrosis. Except for a donation of NAC and a matched placebo by the company that makes the drug, there was no industry support for the work.

IPF, which affects nearly 100,000 Americans, slowly steals the ability to breathe freely. Its cause or causes are not clear, which is why it is called "idiopathic." Over time it leads to the buildup of scar tissue in the lungs that accumulates in a distinctive honeycomb pattern that can be seen on biopsy or CT scan. It is known as an interstitial lung disease because it affects the tissue around the air sacs in the lungs.

IPF patients live an average of five years after diagnosis, though a lung t
'/>"/>

Contact: Kara Gavin
kegavin@umich.edu
734-764-2220
University of Michigan Health System
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. First, Second Kidney Transplants Have Similar Success: Study
2. Second Cancer Often Same Type as the First, Study Finds
3. Cells talk more in areas Alzheimers hits first, boosting plaque component
4. More Young People Delay Sex, Try Oral Sex First, CDC Says
5. 24x7 Infection Control, Inc. Announces World's First, Modern “Shield” Against Microbial Contamination
6. Health care volunteers and disasters: First, be prepared
7. One in 12 Teens Engages in Self-Harm: Report
8. Colon Cleansing Has No Health Benefit, May Harm: Report
9. Study examines treatments for relieving breathing difficulties among patients with lung effusions
10. Study evaluates use of inhaled saline for young children with cystic fibrosis
11. Study says children exposed to tobacco smoke face long-term respiratory problems
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
First, do no harm: Study finds danger in standard treatment for a serious lung disease
(Date:2/27/2015)... If there is one thing that drives ... head lice outbreak at their child’s school. While head lice ... is nothing short of a nightmare for many parents as ... children, or within their child’s classroom. Just when they think ... scratching again. , Local lice removal company, Lice Troopers ...
(Date:2/27/2015)... Philanthropy is a continuous force restoring people’s ... help to restore that faith by helping the people in ... husband/wife Realtor team gives to the local children in need ... while others have been added as the need arose. , ... haven and counseling for women who have suffered physical and ...
(Date:2/27/2015)... NewYork (PRWEB) February 27, 2015 The ... and trends in the global celiac disease market. It ... outlook, research and development activities, and investments. , Celiac ... of gluten damages the small intestine. Celiac disease often ... in every 100 people is affected by celiac disease ...
(Date:2/27/2015)... WI (PRWEB) February 27, 2015 UAS ... Adult Cubes, at Natural Products Expo West, March 6 ... are very excited to release the hands down best ... cream taste with an extra zing of Vitamin C. ... Cubes, winner of the NutrAward 2014, Delicious Living’s Supplement ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 The Willliams ... Plant in Lincoln County, Wyoming. The plant processes ... preparation for interstate natural gas pipeline transport. It also ... The Opal plant initially began operations in 1958, and ... growing natural gas production in Wyoming. The plant ...
Breaking Medicine News(10 mins):Health News:Anxiety over head lice among Miami parents as surge in head lice cases reported by local lice removal company Lice Troopers 2Health News:Mr. And Mrs. Smits Proves That Altruism Works All Year Round 2Health News:Global Celiac Disease Market Counts on Drug Launch for Growth 2Health News:Global Celiac Disease Market Counts on Drug Launch for Growth 3Health News:UAS LifeSciences to Launch UP4 Adult Cubes at Expo West 2Health News:Clean Water Systems Supplies Advanced Chlorine Disinfection Skid for Wyoming Gas Plant 2
... sickening erotica fantasies, two US teenagers in the Florida state ... woman, forcing her 12-year-old son to join the outrage , ... ,Authorities allege Avion Lawson, 14, and Nathan Walker, ... who forced their way into the woman's apartment in a ...
... of The Women's and Children's Hospital, Adelaide in Australia has ... the staff there are exposed to every day. ... of problems with ageing facilities in two of the hospital's ... risk". ,It states: "WCH is experiencing immediate facilities, ...
... Nora Ali, daughter of Bangladeshi immigrants to the United States, ... 17, won the final competition, held in Alabama Saturday, by ... said Wednesday, quoting website wcco.com. ,"I just want ... company with my elder sister who does stem cell research. ...
... developing the world's first vaccine against dengue fever as Singapore ... Friday. ,Clinical tests on up to 3,000 people ... Stephenne, GlaxoSmithKline Biologicals president. ,"We've been working on ... more or less," The Straits Times quoted Stephenne as saying. ...
... researchers say that a single drug for keeping both ... diabetes under check may soon be available. ... Medicine and Pharmacology at Tulane University School of Medicine, ... Sulfonylurea-based therapy has been found to significantly reduce glucose ...
... 36 percent since last year, local press reported Sunday, as ... ,The outbreak has killed 17 people in Thailand ... year, the English-language Nation newspaper reported, quoting figures from the ... by the virus, which is especially dangerous in children and ...
Cached Medicine News:Health News:US Teens Charged With Gang Raping a Woman 2Health News:US Teens Charged With Gang Raping a Woman 3Health News:Concerns Raised Over Risks for Patients and Staff in Australian Hospital 2
(Date:2/26/2015)... MOUNTAIN VIEW, Calif. , Feb. 26, 2015  IRIDEX ... will release its fourth quarter and full year 2014 financial ... 2015.   In conjunction with the release, the Company will ... 5:00 p.m. Eastern Time on Thursday, March 5, ... other business developments. Interested parties may access the ...
(Date:2/26/2015)... 2015 Legislation passed today by the House ... help prevent inappropriate prescriptions in Medicare Part D from ... of Medicare Act (PIMA) of 2014 , introduced by ... (R-TX) and Ranking Member Jim McDermott (D-WA), recognizes ... and implement the right policies, said the Pharmaceutical Care ...
(Date:2/26/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/2vn6hh/radiation_therapy ) has ... - Global Strategic Business Report" report to their ... markets for Radiation Therapy Equipment in US$ Million by ... and Radiation Therapy Simulator. The report provides separate comprehensive ... Japan , Europe ...
Breaking Medicine Technology:IRIDEX Announces Fourth Quarter and Full Year 2014 Conference Call and Release Date 2PCMA Statement on the 'Protecting the Integrity of Medicare Act' 2Radiation Therapy Equipment - Global Strategic Business Report 2015-2020: Linear Accelerator, Treatment Planning Systems, and Radiation Therapy Simulator 2
... Neurobiological Technologies, Inc. (Nasdaq: NTII ) ("NTI") announced ... dividend of $0.18 per share of common stock, which will ... as of November 30, 2009. The December 9, 2009 extraordinary ... to a plan of complete liquidation and dissolution and an ...
... , , WAYNE, Pa., Nov. 20 ... its fiscal first quarter ended September 30, 2009. ... decreased approximately $234,000, or 2.7%, to $8,435,000 during the three-month ... period last fiscal year. The Company reported the decreased ...
Cached Medicine Technology:Neurobiological Technologies Announces Extraordinary Dividend of $0.18 per Share 2Escalon(R) Reports First Quarter Fiscal 2010 Results 2Escalon(R) Reports First Quarter Fiscal 2010 Results 3Escalon(R) Reports First Quarter Fiscal 2010 Results 4Escalon(R) Reports First Quarter Fiscal 2010 Results 5Escalon(R) Reports First Quarter Fiscal 2010 Results 6Escalon(R) Reports First Quarter Fiscal 2010 Results 7